肺癌低剂量CT查中的肺结节管理:来自NELSON试验的教训

Danrong Zhong1, Grigory Sidorenkov1, Colin Jacobs1

  • 1From the Departments of Epidemiology (D.Z., G.S., G.H.d.B., M.A.H.), Radiology (G.S., M.P., R.V.), and Pulmonary Disease (H.J.M.G.), University of Groningen, University Medical Center Groningen, Hanzeplein 1, Postbus 30.001, 9700RB Groningen, the Netherlands; Department of Medical Imaging, Diagnostic Image Analysis Group, Radboud University Medical Center, Nijmegen, the Netherlands (C.J., M.P.); Department of Radiology, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands (P.A.d.J.); Department of Radiology and Nuclear Medicine, Maastricht University, Maastricht University Medical Center, Maastricht, the Netherlands (H.A.G.); GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (H.A.G.); Department of Pulmonary Medicine, University of Rotterdam, University Medical Center Rotterdam, Rotterdam, the Netherlands (R.S., J.G.A.); Department of Respiratory Oncology, University Hospitals Leuven, Leuven, Belgium (K.N.); Institute for Diagnostic Accuracy, Groningen, the Netherlands (M.A.H.); and Department of Respiratory Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands (M.A.H.).

Radiology
|October 22, 2024
PubMed
概括

低剂量CT查有效降低高风险个体的肺癌死亡率. 本次审查重点关注NELSON试验.